EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor cell–derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer

Zainab Hussain, Claudio Montenegro, Christopher Rovera, Djamila Belghoula, Sarah Simha Tubiana, Pascal Finetti, Eugenie Lohmann, Magda Rodrigues, Thomas Bertran, Ghislain Bidaut, Daniel Isnardon, Sophie Vasseur und 5 weitere

Journal of Clinical Investigation · 17.08.2026 · 136 (16)

DOI: 10.1172/jci197733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.07.2026. Verfasst von Zainab Hussain und 16 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center of Marseille (CRCM), Aix-Marseille University, INSERM U1068, CNRS UMR7258, Institute Paoli-Calmettes, Marseille, France. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Extracellular Vesicles, Tumor Microenvironment, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation de France, Institut National Du Cancer, Fondation ARC pour la Recherche sur le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer remains a devastating disease with limited therapeutic options. Accumulating evidence shows that cancer-associated fibroblasts (CAFs) and tumor-associated macrophages, the predominant cells in the pancreatic cancer (PDAC) tumor microenvironment, hinder antitumor immunity. However, the role of extracellular vesicles (EVs) in such a process is poorly understood. In this study, using human bone marrow–derived monocytes and PDAC tumor cells, we showed that tumor cell–derived EVs (TC-EVs) induced monocyte differentiation toward M2-like, immunosuppressive, CD200R + PD-L1 + HLA-DR lo macrophages that express ALOX15B, that we identify as an independent PDAC poor-prognosis biomarker using a human PDAC metacohort. We also demonstrated that TC-EVs reprogrammed human primary PDAC CAFs, causing a fibronectin network reorganization associated with changes in extracellular matrix (ECM) composition, including alterations of WNT pathway elements such as secreted frizzled related protein-1 (SFRP1) enrichment. We also revealed that monocytes cultured on SFRP1–enriched ECM differentiated into M2-like, immunosuppressive macrophages. Last, we demonstrated that both directly and indirectly TC-EV– or SFRP1-enriched ECM–driven differentiated macrophages hindered T cell activation and subsequent antitumor activity. Our findings highlight potentially novel dual mechanisms of TC-EV–mediated crosstalk, involving ALOX15B + macrophages and SFRP1 + CAFs, that simultaneously contribute to foster the immunosuppressive ecosystem of PDAC. This work reveals that extracellular vesicles produced by tumor cells modulate non-tumoral cells behavior to foster the establishment of an immunosppressive ecosystem, in pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsExtracellular VesiclesTumor MicroenvironmentCarcinoma, Pancreatic DuctalHumansMonocytesCell Line, TumorCancer-Associated FibroblastsMacrophagesAnimalsNeoplasm ProteinsTumor-Associated MacrophagesArachidonate 15-Lipoxygenase

Stichwörter der Autor:innen

CancerCell biologyExtracellular matrixGastroenterologyImmunologyMonocytes

Substanzen

Neoplasm ProteinsALOX15 protein, humanArachidonate 15-Lipoxygenase

Autor:innen und Institutionen

  • Cancer Research Center of Marseille (CRCM), Aix-Marseille University, INSERM U1068, CNRS UMR7258, Institute Paoli-Calmettes, Marseille, France.
  • Therapeutic Innovation Center, Federal University of Pernambuco, Recife, Brazil.
  • Department of Medical Oncology, Institute Paoli-Calmettes, Marseille, France.

Förderung

  • Fondation de France
  • Institut National Du Cancer
  • Fondation ARC pour la Recherche sur le Cancer
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Ligue Contre le Cancer

Zitieren

APA

Hussain, Z., Montenegro, C., Rovera, C., Belghoula, D., Tubiana, S. S., Finetti, P., Lohmann, E., Rodrigues, M., Bertran, T., Bidaut, G., Isnardon, D., Vasseur, S., Bertucci, F., Audebert, S., Camoin, L., Rego, M., & Tomasini, R. (2026). Tumor cell–derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer. Journal of Clinical Investigation, 136(16). https://doi.org/10.1172/jci197733

Vancouver

Hussain Z, Montenegro C, Rovera C, Belghoula D, Tubiana SS, Finetti P, et al. Tumor cell–derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer. Journal of Clinical Investigation. 2026;136(16). doi:10.1172/jci197733

BibTeX
@article{Hussain2026,
  author = {Hussain, Zainab and Montenegro, Claudio and Rovera, Christopher and Belghoula, Djamila and Tubiana, Sarah Simha and Finetti, Pascal and Lohmann, Eugenie and Rodrigues, Magda and Bertran, Thomas and Bidaut, Ghislain and Isnardon, Daniel and Vasseur, Sophie and Bertucci, Francois and Audebert, Stephane and Camoin, Luc and Rego, Moacyr and Tomasini, Richard},
  title = {Tumor cell–derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  volume = {136},
  number = {16},
  doi = {10.1172/jci197733}
}
Kostenlos starten →